研究文章
最近的趋势在儿科患者的甲状腺结节的临床病理学特征:一个三级中心经验超过25年
|
|
1990年至1995年(n= 42) |
1996年至2000年(n= 50) |
2001年至2005年(n= 40) |
2006年至2010年(n= 38) |
2011年至2014年(n= 45) |
价值 |
|
| 年龄、年(意思是,SD) |
15 |
±3.624 |
15 |
±3.138 |
15 |
±3.342 |
15 |
±2.857 |
15 |
±3.078 |
0.218 |
| 年龄组 |
|
|
|
|
|
|
|
|
|
|
0.892 |
| 清廉 |
4 |
9.5% |
8 |
16.0% |
4 |
10.0% |
3 |
7.9% |
5 |
11.1% |
|
| 11 - 15号 |
17 |
40.5% |
16 |
32.0% |
12 |
30.0% |
16 |
42.1% |
18 |
40.0% |
|
| 16日至18日 |
21 |
50.0% |
26 |
52.0% |
24 |
60.0% |
19 |
50.0% |
22 |
48.9% |
|
| 性 |
|
|
|
|
|
|
|
|
|
|
0.149 |
| 女性 |
35 |
83.3% |
35 |
70.0% |
35 |
87.5% |
32 |
84.2% |
31日 |
68.9% |
|
| 男性 |
9 |
21.4% |
15 |
30.0% |
5 |
12.5% |
6 |
15.8% |
14 |
31.1% |
|
| 主诉导致住院 |
|
|
|
|
|
|
|
0.061 |
|
|
|
| Incidentaloma |
0 |
|
1 |
2.0% |
3 |
7.5% |
6 |
15.8% |
11 |
24.4% |
|
| 前脖子上明显的质量 |
37 |
88.1% |
42 |
84.0% |
33 |
82.5% |
26 |
68.4% |
27 |
60.0% |
|
| 侧颈部明显的质量 |
1 |
2.4% |
2 |
4.0% |
0 |
|
2 |
5.3% |
2 |
4.4% |
|
| 脖子不舒服 |
0 |
|
0 |
|
0 |
|
2 |
5.3% |
1 |
2.2% |
|
| 声音沙哑 |
0 |
|
1 |
2.0% |
0 |
|
0 |
|
1 |
2.2% |
|
| 呼吸困难 |
1 |
2.4% |
0 |
|
1 |
2.5% |
0 |
|
1 |
2.2% |
|
| 未知的 |
3 |
7.1% |
4 |
8.0% |
3 |
7.5% |
2 |
5.3% |
2 |
4.4% |
|
| 细针吸活组织录取 |
|
|
|
|
|
|
|
|
≤0.00 |
|
|
| 是的 |
17 |
40.5% |
36 |
72.0% |
31日 |
77.5% |
36 |
94.7% |
41 |
91.1% |
|
| 没有 |
25 |
59.5% |
14 |
28.0% |
9 |
22.5% |
2 |
5.3% |
4 |
8.9% |
|
| 最初的细胞学 |
|
|
|
|
|
|
|
|
|
|
≤0.00 |
| Nondiagnostic或不满意 |
0 |
|
1 |
2.8% |
0 |
|
0 |
|
0 |
|
|
| 良性的 |
7 |
41.2% |
6 |
16.7% |
4 |
12.9% |
3 |
8.3% |
3 |
7.3% |
|
| 异型性待定意义或滤泡损伤待定的意义 |
1 |
5.9% |
1 |
2.8% |
6 |
19.4% |
2 |
5.6% |
5 |
12.2% |
|
| 滤泡性肿瘤或滤泡性肿瘤的怀疑 |
2 |
11.8% |
8 |
22.2% |
2 |
6.5% |
2 |
5.6% |
3 |
7.3% |
|
| 怀疑恶性肿瘤 |
2 |
11.8% |
2 |
5.6% |
1 |
3.2% |
2 |
5.6% |
4 |
9.8% |
|
| 恶性 |
5 |
29.4% |
16 |
44.4% |
18 |
58.1% |
27 |
75.0% |
26 |
63.4% |
|
| 其他(神经鞘瘤和脓肿) |
0 |
|
2 |
5.6% |
0 |
|
0 |
|
0 |
|
|
| 最后病理甲状腺切除术后 |
|
|
|
|
|
|
|
|
|
|
≤0.00 |
| 良性的 |
32 |
76.2% |
24 |
48.0% |
16 |
40.0% |
5 |
13.2% |
10 |
22.2% |
|
| 甲状腺机能亢进(弥漫性增生) |
13 |
40.6% |
12 |
50.0% |
7 |
43.8% |
1 |
20.0% |
4 |
40.0% |
|
| 腺瘤甲状腺肿/结节性增生 |
13 |
40.6% |
5 |
20.8% |
3 |
18.8% |
3 |
60.0% |
2 |
20.0% |
|
| 桥本甲状腺炎 |
1 |
3.1% |
1 |
4.2% |
0 |
|
0 |
|
0 |
|
|
| 滤泡腺瘤 |
5 |
15.6% |
2 |
8.3% |
6 |
37.5% |
1 |
20.0% |
4 |
40.0% |
|
| 许特耳氏细胞腺瘤 |
0 |
|
2 |
8.3% |
0 |
|
0 |
|
0 |
|
|
| 其他(神经鞘瘤和脓肿) |
0 |
|
2 |
8.3% |
0 |
|
0 |
|
0 |
|
|
| 恶性 |
10 |
23.8% |
27 |
54.0% |
24 |
60.0% |
33 |
86.8% |
35 |
77.8% |
|
| 乳头状甲状腺癌 |
8 |
80.0% |
20. |
74.1% |
20. |
83.3% |
28 |
84.8% |
29日 |
82.9% |
|
| 滤泡性甲状腺癌 |
2 |
20.0% |
4 |
14.8% |
4 |
16.7% |
5 |
15.2% |
6 |
17.1% |
|
| 乳头状、滤泡性甲状腺癌 |
0 |
|
1 |
3.7% |
0 |
|
0 |
|
0 |
|
|
| 由甲状腺切除术后病理肿瘤大小(厘米) |
2.5 |
(1.2 - -4.0) |
2.5 |
(1.0 - -6.5) |
3.0 |
(1.0 - -6.0) |
2.5 |
(0.5 - -6.0) |
2.6 |
(0.4 - -8.0) |
0.849 |
|
|
